scPharmaceuticals Inc.

NasdaqGS:SCPH

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

United States

Market Cap

USD 206.94 M

Share Price

USD 3.84

Avg Daily Volume

458,441

Change (1 day)

-2.04%

Change (1 year)

-4.95%

Change (YTD)

8.48%

scPharmaceuticals Inc. Share Price on June 20, 2025: USD 3.84

scPharmaceuticals Inc. Share Price is USD 3.84 on June 20, 2025, a -4.95% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

scPharmaceuticals Inc. 52-week low Share Price is USD 5.51 on June 20, 2025, which is 43.49% above the current Share Price.
scPharmaceuticals Inc. 52-week low Share Price is USD 2.02 on June 20, 2025, which is -47.40% below the current Share Price.
scPharmaceuticals Inc. average Share Price for the last 52 weeks is USD 3.78.

Daily

From:

To:

Zoom:

Key data

Date	Share Price	Share Price	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)

NasdaqGS: SCPH

scPharmaceuticals Inc.

CEO	Mr. John H. Tucker
IPO Date	Nov. 17, 2017
Location	United States
Headquarters	2400 District Avenue
Employees	162
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies

Description

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.